Figure 1
Figure 1. CXCR1 expression on effector subsets in human peripheral CD8+ T cells. (A) Differential expression of perforin and CXCR1 on/in CD27−CD28−CD45RA+/− subsets of human CD8+ T cells in freshly isolated PBMCs is shown as 1 representative result from 4 healthy individuals. The values in each plot show the frequency of each population. (B) Gene-expression profiles of CXCR1+ and CXCR1− cells in the CD27−CD28− effector subset, the CD27highCD28+CD45RA+ naive subset, and the CD27+CD28+CD45RA− memory subset are shown as the mean relative gene-expression levels and SD from 4 healthy individuals. (C) HCMV-1-A*0201 tetramer+ cells among PBMCs from a HCMV-seropositive healthy individual (U-14) were analyzed for their CXCR1 expression. The percentage of CXCR1+ cells in each CD27CD28 subset of tetramer-positive cells was also determined. (D) Cytolytic activities of CXCR1+ and CXCR1− cells in the effector subset toward C1R-A*0201 cells prepulsed with the HCMV-1 pp65 495-503 peptide.

CXCR1 expression on effector subsets in human peripheral CD8+ T cells. (A) Differential expression of perforin and CXCR1 on/in CD27CD28CD45RA+/− subsets of human CD8+ T cells in freshly isolated PBMCs is shown as 1 representative result from 4 healthy individuals. The values in each plot show the frequency of each population. (B) Gene-expression profiles of CXCR1+ and CXCR1 cells in the CD27CD28 effector subset, the CD27highCD28+CD45RA+ naive subset, and the CD27+CD28+CD45RA memory subset are shown as the mean relative gene-expression levels and SD from 4 healthy individuals. (C) HCMV-1-A*0201 tetramer+ cells among PBMCs from a HCMV-seropositive healthy individual (U-14) were analyzed for their CXCR1 expression. The percentage of CXCR1+ cells in each CD27CD28 subset of tetramer-positive cells was also determined. (D) Cytolytic activities of CXCR1+ and CXCR1 cells in the effector subset toward C1R-A*0201 cells prepulsed with the HCMV-1 pp65 495-503 peptide.

Close Modal

or Create an Account

Close Modal
Close Modal